<DOC>
	<DOCNO>NCT02359123</DOCNO>
	<brief_summary>The main purpose treatment patient advanced cancer cancer anorexia cachexia syndrome ( CACS ) prolong life improve quality life ( QoL ) far possible . QoL patient CACS directly related loss appetite loss weight . Cannabis pill give Israel advance cancer patient various symptom order improve QoL . There data safety/toxicity cannabis , pill give regulation Israel Ministry Health . The purpose study examine influence Cannabics capsule improve loss appetite loss weight .</brief_summary>
	<brief_title>Cannabics Capsules Treatment Improve Cancer Related CACS Advanced Cancer Patients</brief_title>
	<detailed_description>Cannabis long suggest stimulate appetite , decrease nausea vomiting , improve quality life cancer patient . Studies efficacy cannabis improve CACS S-NIS mixed result . After trial show improvement weight gain among AIDS patient , cannabinoids test cancer patient well . In controlled , random study compare dronabinol placebo among cancer patient , dronabinol associate increase appetite 38 % vs 8 % placebo , decrease nausea 20 % vs 7 % , use acceptable measurement scale . Of dronabinol patient , 22 % gain ≥2 kg , compare 10.5 % placebo recipient , datum reach significance , perhaps due advanced stage cancer high mortality placebo experimental group ( 30 ) . Another randomize study compare dronabinol megestrol acetate treatment together . The research include 469 advanced cancer patient suffer substantial appetite loss . A great percentage megestrol acetate-treated patient report appetite improvement compare dronabinol-treated patient , 75 % vs 49 % ( p=0.0001 ) . Combination treatment result significant difference compare megestrol acetate alone . Another study , include 243 patient , compare administration combination tetrahydrocannabinol cannabinol tetrahydrocannabinol alone , compare placebo . It note cannabinoid dosage study low , even comparison study . No significant difference group see regard improvement appetite weight-gain . In two study , substantial side effect cannabis product find compare arm . This may relate dosage drug give . A recent study demonstrate improved chemosensory perception , appetite , sleep , macronutrient preference advance cancer patient . However , study include less 50 patient . This research show improvement taste smell perception patient receive chemotherapy , well appetite caloric intake arm receive dronabinol compare placebo . Assessment : Base-line assessment 1 . Physician anamnesis physical examination 2 . Complete blood cell count ( CBC ) biochemistry test : electrolyte , renal liver function test , albumin level , total cholesterol level 3 . Blood test TNF-alpha level 4 . Nutrition evaluation , include daily caloric calculation ( use 3 day food diary ) weight patient 5 . QoL assessment EORTC C30 Anorexia/Cachexia Therapy assessment FAACT questionnaire 6 . Evaluation muscle strength use hand dynamometer estimation muscle mass . Treatment assessment 1 . Physician anamnesis include toxicity assessment accord CTCAE recommendation acute toxicity , physical examination include weigh patient every two week first month , every month come two month , every six week next three month 2 . CBC , biochemistry blood test , TNF-alpha level day 1 , three month 3 . Nutritional intake evaluation first week three month , base daily caloric calculation three day food diary 4 . Muscle strength evaluation day 1 three month 5 . QOL assessment EORTC C30 Anorexia/Cachexia Therapy assessment FAACT questionnaire day 1 three six month 6 . Safety assessment early psychiatric side-effects Community Assessment Psychic Experiences ( CAPE ) questionnaire day 1 2 week 3 month . 7 . Urine THC- level one day 1 , 2 week , 3 month . Quality-of-Life ( QOL ) Assessment QOL assess use European Organization Research Treatment Cancer core question Quality Life Questionnaire , version 2 ( QLQ-C30 ) ( 43 ) Anorexia/Cachexia Therapy ( FAACT ) questionnaire ( 44 ) . Nutrition assessment 1 . Daily caloric calculation base three day food diary . On day 1 , patient meet dietitian receive guidance instruction complete diary . The cannabis pill give day 4 , bring back three day diary . After three month , patient three day food diary caloric calculation make . 2 . The caloric calculation make Ministry Health Computer software `` Zameret '' . 3 . The patient telephone support dietitian need day diary completion . 4 . Cannabics capsule give day 4 , bring back three day diary . Safety assessment : Community Assessment Psychic Experiences ( CAPE ) questionnaire evaluate possible early psychiatric side-effects give 3 time point , together measure THC level urine . Evaluation side-effects do every physician visit .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>1 . Age 18 year 2 . Histological evidence incurable malignancy 3 . Estimated life expectancy ≥3 month 4 . Performance status ≤2 ( ECOG classification ) 5 . Selfreport weight loss least 3kg precede 2 month and/or dietitianestimated caloric intake less 20 calories/kg body weight per day 6 . Patient believe loss appetite loss weight ongoing problem 7 . Use chemotherapy radiotherapy permit 8 . Sign write informed consent 1 . Ongoing use tube feeding parental nutrition 2 . Edema ascites 3 . Central nervous system metastases brain tumor ( patient stable disease brain 28 day treatment include study ) 4 . Treatment adrenal corticosteroid ( except shortterm dexamethasone time chemotherapy ) , androgens , progestational agent appetite stimulant within previous two week 5 . Insulinrequiring diabetes 6 . Pregnancy lactation unwillingness use oral contraceptive 7 . Other lifethreatening medical condition 8 . Anticipated alcohol barbiturate use study period 9 . Mechanical obstruction alimentary tract , malabsorption , intractable vomit 10 . Use cannabis synthetic cannabinoids last four week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>